Public Stock Offering
-
Malvern’s Recro Pharma Looking to Raise $15 Million from Public Stock Offering
Malvern’s Recro Pharma is looking to raise $15 million through a public stock offering. Most of the funds are earmarked for ongoing late stage testing…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
